55 related articles for article (PubMed ID: 7417768)
1. Cloxacillin - A new cause of pill-induced esophagitis.
Zezos P; Harel Z
Can J Gastroenterol Hepatol; 2015 Sep; ():. PubMed ID: 26359625
[No Abstract] [Full Text] [Related]
2. Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.
Maiuri AR; Wassink B; Turkus JD; Breier AB; Lansdell T; Kaur G; Hession SL; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2017 Sep; 362(3):459-473. PubMed ID: 28687704
[TBL] [Abstract][Full Text] [Related]
3. Severe cholestatic hepatitis following cloxacillin treatment.
Goland S; Malnick SD; Gratz R; Feldberg E; Geltner D; Sthoeger ZM
Postgrad Med J; 1998 Jan; 74(867):59-60. PubMed ID: 9538497
[TBL] [Abstract][Full Text] [Related]
4. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
[TBL] [Abstract][Full Text] [Related]
5. Nafcillin-associated hepatotoxicity. Report of a case and review of the literature.
Presti ME; Janney CG; Neuschwander-Tetri BA
Dig Dis Sci; 1996 Jan; 41(1):180-4. PubMed ID: 8565754
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced cholestasis.
Zimmerman HJ; Lewis JH
Med Toxicol; 1987; 2(2):112-60. PubMed ID: 3553833
[TBL] [Abstract][Full Text] [Related]
7. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin).
Stricker BH; Van den Broek JW; Keuning J; Eberhardt W; Houben HG; Johnson M; Blok AP
Dig Dis Sci; 1989 Oct; 34(10):1576-80. PubMed ID: 2791808
[TBL] [Abstract][Full Text] [Related]
8. Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis.
Dowsett JF; Gillow T; Heagerty A; Radcliffe M; Toadi R; Isle I; Russell RC
Dig Dis Sci; 1989 Aug; 34(8):1290-3. PubMed ID: 2752877
[TBL] [Abstract][Full Text] [Related]
9. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
Faragalla K; Lau H; Wang HL; Liu J
Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
[TBL] [Abstract][Full Text] [Related]
10. Cloxacillin-induced cholestasis.
Lotric S; Lejko-Zupanc T; Jereb M
Clin Infect Dis; 1994 Nov; 19(5):981-2. PubMed ID: 7893901
[No Abstract] [Full Text] [Related]
11. Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.
Enat R; Pollack S; Ben-Arieh Y; Livni E; Barzilai D
Br Med J; 1980 Apr; 280(6219):982-3. PubMed ID: 7417768
[TBL] [Abstract][Full Text] [Related]
12. Cloxacillin-induced cholestatic jaundice.
Konikoff F; Alcalay J; Halevy J
Am J Gastroenterol; 1986 Nov; 81(11):1082-3. PubMed ID: 3776959
[TBL] [Abstract][Full Text] [Related]
13. Use of macrophage inhibition factor and mast-cell degranulation tests for diagnosis of cloxacillin-induced cholestasis.
Aderka D; Livni E; Salamon F; Weinberger A; Pinkhas J
Am J Gastroenterol; 1986 Nov; 81(11):1084-6. PubMed ID: 3776960
[TBL] [Abstract][Full Text] [Related]
14. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
Victorino RM; Maria VA; Correia AP; de Moura C
Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
[TBL] [Abstract][Full Text] [Related]
15. Flucloxacillin-induced cholestatic liver damage.
Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
